Variant report

Variant	esv3510759
Chromosome Location	chr2:182856830-182857634
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr2:182856985..182859810-chr2:182861410..182863046,2	MCF-7	breast:
2	chr2:182851614..182854352-chr2:182854697..182857369,2	MCF-7	breast:

Extended variants
information (count: 26 )
Associated
traits (count: 52 )

Variant overlapped rSNPs/rCNVs (count:26 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs538529818	chr2:182856870-182856871	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs555006394	chr2:182856900-182856901	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs574801463	chr2:182856911-182856912	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs183984382	chr2:182856963-182856964	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs187317357	chr2:182856965-182856966	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs373014819	chr2:182856982-182856983	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs56177617	chr2:182857014-182857015	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs115400601	chr2:182857027-182857028	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs377373991	chr2:182857067-182857068	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs529140105	chr2:182857071-182857072	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs562481010	chr2:182857118-182857119	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs531252813	chr2:182857131-182857132	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs548453009	chr2:182857136-182857137	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs532995968	chr2:182857138-182857139	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs527585690	chr2:182857223-182857224	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs182243536	chr2:182857240-182857241	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs570696318	chr2:182857286-182857287	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs77674133	chr2:182857292-182857293	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs16867519	chr2:182857312-182857313	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs569226006	chr2:182857362-182857363	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs535179941	chr2:182857401-182857402	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs569463204	chr2:182857473-182857474	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs370994627	chr2:182857504-182857505	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs538760493	chr2:182857524-182857525	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs140631241	chr2:182857528-182857529	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs537814040	chr2:182857597-182857598	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:52)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	18522746	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Lung cancer	18438408	CNVD
Glioblastoma	21080181	CNVD
Prostate cancer	18632612	CNVD
Sudden cardiac death	19188705	CNVD
Acute myeloid leukemia	20729466	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
small cell lung cancer	20016488	CNVD
Facial dysmorphism	20548289	CNVD
Mental retardation	20548289	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Cancer	21183584	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Ovarian clear cell carcinoma	21343371	CNVD

Chromatin state (count:16 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:182843400-182904000	Weak transcription	Thymus	Thymus
2	chr2:182845400-182879000	Weak transcription	Fetal Thymus	thymus
3	chr2:182853400-182859400	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
4	chr2:182854200-182857800	Weak transcription	Psoas Muscle	Psoas
5	chr2:182856000-182857000	Enhancers	Primary B cells from cord blood	blood
6	chr2:182856000-182857000	Enhancers	Primary hematopoietic stem cells short term culture	blood
7	chr2:182856000-182857000	Enhancers	Duodenum Smooth Muscle	Duodenum
8	chr2:182856000-182857000	Enhancers	Fetal Intestine Small	intestine
9	chr2:182856000-182857200	Enhancers	Primary monocytes fromperipheralblood	blood
10	chr2:182856000-182857200	Enhancers	Monocytes-CD14+_RO01746	blood
11	chr2:182856000-182858000	Enhancers	Fetal Heart	heart
12	chr2:182856200-182857000	Enhancers	Primary B cells from peripheral blood	blood
13	chr2:182856800-182857000	Flanking Active TSS	GM12878-XiMat	blood
14	chr2:182857000-182857200	Enhancers	GM12878-XiMat	blood
15	chr2:182857200-182857400	Flanking Active TSS	GM12878-XiMat	blood
16	chr2:182857400-182857800	Enhancers	GM12878-XiMat	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links